When is QT prolongation antiarrhythmic and when is it proarrhythmic?

This publication has 14 references indexed in Scilit:

• Incidence and clinical relevance of QT prolongation caused by the new selective serotonin antagonist ketanserin
  The American Journal of Cardiology, 1989
• Acute and chronic effects of ketanserin on the electrophysiologic properties of isolated rabbit ventricular myocardium: Particular reference to repolarization
  American Heart Journal, 1988
• Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patient care
  American Heart Journal, 1986
• Nine cases of torsade de pointes with bepridil administration
  American Heart Journal, 1986
• Idiopathic long QT syndrome: Progress and questions
  American Heart Journal, 1985
• Comparison of lidoflazine and quindine in prophylactic treatment of arrhythmias.
  Heart, 1977
• VENTRICULAR ARRHYTHMIAS AND HYPOKALÆMIA
  The Lancet, 1976
• The effect of amiodarone, a new anti‐anginal drug, on cardiac muscle
  British Journal of Pharmacology, 1970
• A third class of anti‐arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474
  British Journal of Pharmacology, 1970
• Quinidine Syncope
  Circulation, 1964